1-232402396-C-T
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_020808.5(SIPA1L2):c.5018G>A(p.Arg1673Gln) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000843 in 1,612,846 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a benign outcome for this variant. 13/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. R1673W) has been classified as Uncertain significance.
Frequency
Consequence
NM_020808.5 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 0 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.0000854 AC: 13AN: 152162Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.0000682 AC: 17AN: 249144Hom.: 0 AF XY: 0.0000666 AC XY: 9AN XY: 135188
GnomAD4 exome AF: 0.0000842 AC: 123AN: 1460684Hom.: 1 Cov.: 30 AF XY: 0.0000826 AC XY: 60AN XY: 726632
GnomAD4 genome AF: 0.0000854 AC: 13AN: 152162Hom.: 0 Cov.: 33 AF XY: 0.0000404 AC XY: 3AN XY: 74328
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Nov 06, 2024 | The c.5018G>A (p.R1673Q) alteration is located in exon 20 (coding exon 20) of the SIPA1L2 gene. This alteration results from a G to A substitution at nucleotide position 5018, causing the arginine (R) at amino acid position 1673 to be replaced by a glutamine (Q). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at